All data are based on the daily closing price as of September 6, 2024
e
Ever Fortune.AI
6841.TWO
2.67 USD
0.07
+2.69%
Overview
Last close
2.67 usd
Market cap
263.54M usd
52 week high
4.59 usd
52 week low
2.56 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
38.8264
Price/Book Value
4.3844
Enterprise Value
214.29M usd
EV/Revenue
32.3838
EV/EBITDA
-167.2623
Key financials
Revenue TTM
6.62M usd
Gross Profit TTM
N/A usd
EBITDA TTM
-905463.63 usd
Earnings per Share
-0.02 usd
Dividend
N/A usd
Total assets
N/A usd
Net debt
N/A usd
About
Ever Fortune.AI Co., Ltd. provides artificial intelligence cloud services. It offers bone age assessment system that assists doctors in bone age assessment and predicting a child's final height; and breast ultrasound tumor classification system, which assists doctors in the diagnosis of the tumor, non-invasive screening of breast puncture, and biopsy to determine the malignancy of the breast tumor. The company also provides computer tomography liver cancer metastatic risk assessment system that enhances the radiologist's efficiency and assesses the metastatic risk of liver cancer; liver fibrosis assessment system to assess liver fibrosis; and an atrial fibrillation detection system that interprets the electrocardiogram signal and assesses the condition of the heart. Ever Fortune.AI Co., Ltd. is based in Taichung City, Taiwan. Ever Fortune.AI Co., Ltd operates as a subsidiary of An Ji Biomedical Corporation.